Safety and efficacy of anlotinib combined with taxane and lobaplatin in neoadjuvant treatment of clinical stage II/III triple-negative breast cancer in China (the neoALTAL trial): a single-arm, phase 2 trial
在中国,安罗替尼联合紫杉烷类和洛铂新辅助治疗II/III期三阴性乳腺癌的安全性和有效性(neoALTAL试验):一项单臂II期试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2024.102585
Liang, Yan; Liu, Jing; Ge, Jia; Shi, Qiyun; Zhang, Guozhi; Wan, Andi; Luo, Tao; Tian, Hao; Fan, Linjun; Wang, Shushu; Chen, Li; Tang, Peng; Zhu, Kai; Jiang, Jun; Bian, Xiuwu; Zhang, Yi; Qi, Xiaowei